Skip to main content
SpringerLink
Log in

Ethical and Legal Issues in Genetic Testing for Cancer Susceptibility

  • Chapter
Cancer Genetics for the Clinician

  • 79 Accesses

Abstract

Genetic testing for cancer susceptibility is new and therefore deserves the careful attention of physicians in order to assure that the tests are performed and interpreted in an appropriate fashion. On occasion, genetic testing for cancer susceptibility will present ethical dilemmas with which many clinicians will not be familiar. A brief case presentation will frame these issues for subsequent discussion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Geller G, Botkin J, Green M, Press N, Biesecker B, et al: Genetic testing for susceptibility to adult-onset cancer: the process and content of informed consent. JAMA 277:1467–1474, 1997

    Article  PubMed  CAS  Google Scholar 

  2. MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774, 1990

    Article  PubMed  CAS  Google Scholar 

  3. Anon: Classification, Prevalence, Detection, and Evaluation. Circulation 89:1344–1356, 1994

    Google Scholar 

  4. Lerman C, Narod S, Schulman K, Hughs C, et al: BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275:1885–1892, 1996

    Article  PubMed  CAS  Google Scholar 

  5. Burke W, Daly M, Garber J, Botkin J, et al: Recommendations for follow-up care of individuals with inherited predisposition to cancer: BRCA1 and BRCA2. JAMA 277:997–1003, 1997

    Article  PubMed  CAS  Google Scholar 

  6. Burke W, Petersen G, Lynch P, Botkin J, Daly M, et al: Recommendations for follow-up care of individuals with inherited predisposition to cancer: hereditary nonpolyposis colon cancer. JAMA 277:915–919, 1997

    Article  PubMed  CAS  Google Scholar 

  7. Murray T: Genetic exceptionalism, and “future diaries”: Is genetic information different from other medical information? in Rothstein M (Ed) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. Yale University Press, New Haven, 60–73, 1997

    Google Scholar 

  8. Strohman RC: The coming Kuhnian revolution in biology. Nature Biotechnology 15:194–200, 1997

    Article  PubMed  CAS  Google Scholar 

  9. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785, 1994

    Article  Google Scholar 

  10. Collins FS: BRCA1—Lots of mutations, lots of dilemmas. N Engl J Med 334:186–188, 1996

    Article  PubMed  CAS  Google Scholar 

  11. American Society of Human Genetics. Statement of the American Society of Human Genetics on Genetic Testing for Breast and Ovarian Cancer Predisposition. Am J Hum Genet 55:i–iv, 1994

    Google Scholar 

  12. Visco F: Commentary on the ASCO statement on genetic testing for cancer susceptibility [press release] Washington, DC, National Breast Cancer Coalition

    Google Scholar 

  13. Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility. J Clin Oncology 14:1730–1736, 1996

    Google Scholar 

  14. Mark Skolnick, Ph.D., Myriad Genetics, 1996

    Google Scholar 

  15. Task Force on Genetic Testing. Promoting Safe and Effective Genetic Testing in the United States:Final Report of the Task Force on Genetic Testing. Holtzman NA, Watson MS (Eds) available at http://www.nhgri.nih.gov/ELSI/TFGT_final/

  16. Croyle R, Smith K, Botkin J, Baty B, Nash J: Psychological responses to BRCA1 mutation testing:preliminary findings. Health Psychology 16:63–72, 1997

    Article  PubMed  CAS  Google Scholar 

  17. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New Engl J Med 336:823–827, 1997

    Article  PubMed  CAS  Google Scholar 

  18. Allen A: Genetic privacy: emerging concepts and values. In Rothstein M (Ed) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. Yale University Press, New Haven, 31–59, 1997

    Google Scholar 

  19. Annas GJ, Glantz L, Roche PA: The Genetic Privacy Act. 1995, Boston: Boston University School of Public Health

    Google Scholar 

  20. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Professional Disclosure of Familial Genetic Information. Am J Hum Genet 62:474–483, 1998

    Article  Google Scholar 

  21. Tarasoff V: Regents of University of California 551 P.2d 334

    Google Scholar 

  22. Pate V: Threkel, 661 So. 2d 278 (1995)

    Google Scholar 

  23. Safer V: Estate of Pack 677 A. 2d 1188

    Google Scholar 

  24. Wertz D, Fletcher J. An international survey of attitudes of medical geneticists toward mass screening and access to results. 1989 Publ Health Reports 104:35–44

    Google Scholar 

  25. Fost N: Genetic diagnosis and treatment: Ethical considerations. AJDC 147:1190–1195, 1993

    PubMed  CAS  Google Scholar 

  26. Botkin J, Croyle RT, Smith KR, Baty B, Lerman C, Goldgar D, Ward J, Flick B, Nash J: A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. JNCI 88:872–882, 1996

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Utah Primary Children’s Medical Center, 100 North Medical Drive, Salt Lake City, Utah, 84113, USA

    Jeffrey R. Botkin (Professor of Pediatrics and Medical Ethics)

Authors
  1. Jeffrey R. Botkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida, USA

    Gail L. Shaw

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Botkin, J.R. (1999). Ethical and Legal Issues in Genetic Testing for Cancer Susceptibility. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4699-3_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7128-1

  • Online ISBN: 978-1-4615-4699-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation